EJNMMI Research publishes new basic, translational and clinical research in the field of nuclear medicine and molecular imaging.
Regular features include original research articles, short communication of preliminary data on innovative research, interesting case reports, editorials, and letters to the editor.
Educational articles on basic sciences, fundamental aspects and controversy related to pre-clinical and clinical research or ethical aspects of research are also welcome.
The journal also considers preliminary Research Articles or short communications that include novel findings, methods or radiopharmaceuticals with a high potential but limited data available, worth a preliminary information.
Timely reviews provide updates on current applications, issues in imaging research and translational aspects of nuclear medicine and molecular imaging technologies.
Topics include but not limited to innovative research covering all aspects of molecular imaging, e.g. radiopharmaceutical approaches with a high potential of clinical impact, important aspects in image reconstruction and accuracy, or within the theranostic field with therapy combinations or incorporation of artificial intelligence in image generation or interpretation.
Announcement
Since January 2024: New Editor-in-Chief - Dr. Irene Burger, Chief Medical Officer, Kantonsspital Baden AG
2022 Citation Impact
3.2 - 2-year Impact Factor
3.3 - 5-year Impact Factor
0.932 - SNIP (Source Normalized Impact per Paper)
0.853 - SJR (SCImago Journal Rank)
2023 Speed
12 days submission to first editorial decision for all manuscripts (Median)
87 days submission to accept (Median)
2023 Usage
604,325 downloads
175 Altmetric mentions
